PIK3CA and PIK3CB inhibition produce synthetic lethality when combined with estrogen deprivation in estrogen receptor-positive breast cancer

Robert J. Crowder, Chanpheng Phommaly, Yu Tao, Jeremy Hoog, Jingqin Luo, Charles M. Perou, Joel S. Parker, Melinda A. Miller, David G. Huntsman, Li Lin, Jacqueline Snider, Sherri R. Davies, John A. Olson, Mark A. Watson, Anthony Saporita, Jason D. Weber, Matthew J. Ellis

Research output: Contribution to journalArticlepeer-review

193 Scopus citations

Fingerprint

Dive into the research topics of 'PIK3CA and PIK3CB inhibition produce synthetic lethality when combined with estrogen deprivation in estrogen receptor-positive breast cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences